Livzon Pharmaceutical Group (SZSE:000513) Total Liabilities : ¥9,750 Mil (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group Total Liabilities?

Livzon Pharmaceutical Group's Total Liabilities for the quarter that ended in Mar. 2024 was ¥9,750 Mil.

Livzon Pharmaceutical Group's quarterly Total Liabilities declined from Sep. 2023 (¥10,331.73 Mil) to Dec. 2023 (¥10,278.12 Mil) and declined from Dec. 2023 (¥10,278.12 Mil) to Mar. 2024 (¥9,750.20 Mil).

Livzon Pharmaceutical Group's annual Total Liabilities increased from Dec. 2021 (¥8,060.89 Mil) to Dec. 2022 (¥9,931.89 Mil) and increased from Dec. 2022 (¥9,931.89 Mil) to Dec. 2023 (¥10,278.12 Mil).

Livzon Pharmaceutical Group Total Liabilities Historical Data

The historical data trend for Livzon Pharmaceutical Group's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Total Liabilities Chart

Livzon Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

5,701.23

6,950.73

8,060.89

9,931.89

10,278.12

Livzon Pharmaceutical Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															10,204.67	11,476.30	10,331.73	10,278.12	9,750.20

Livzon Pharmaceutical Group Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Livzon Pharmaceutical Group's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8087.137	+	(1621.804	+	569.183
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	10,278

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	25044.827	-	14766.703
	=	10,278

Livzon Pharmaceutical Group's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8329.92	+	(864.402	+	555.873
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	9,750

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	25189.696	-	15439.501
	=	9,750

Livzon Pharmaceutical Group Total Liabilities Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Livzon Pharmaceutical Group (SZSE:000513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » Total Liabilities

Traded in Other Exchanges

01513:Hong Kong LP6:Germany

Address

38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090

Website

https://www.livzon.com.cn

Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines